Market closed·Syncing…
SMEMarket closed · Close · 19 Nov

Vaidya Sane Ayurved Laboratories Limited MADHAVBAUGshare price and chart

Vaidya Sane Ayurved Laboratories closed at ₹154.50 on 19 November 2026, down 4.51% on the day. The 52-week range is ₹130.05 to ₹335.00.

₹154.50The price one share last traded at, in rupees.▼ 4.51% · ₹7.30
52-wk low ₹13012% up the rangeThe highest and lowest price the share has traded at in the past year, and where today's price sits between the two.high ₹335

Daily candlesEach candle is one trading day. The chart opens on the last year; drag back past the start or open full screen and the rest loads, back to listing (or the first day in our data). The body runs from the open to the close, the thin lines to the high and low. Green closed up, red closed down.

Loading prices…

Split and bonus adjusted daily candles. Drag back past the start, or open full screen, and its whole history loads. Scroll or pinch to zoom; full screen adds indicators, drawing and measuring.

Test a strategy on MADHAVBAUG

Real prices, every charge counted. Pick one or write your own.

Technical snapshotHow the share has been behaving: its momentum, its trend, how much of the trading was real buying to keep, and its returns.

EOD 19 Nov
RSI (14) · 30 oversold, 70 overboughtA score from 0 to 100 showing how strong recent up days were against recent down days.
52.2Neutral
0 oversold3070overbought 100
Delivery · bought to hold vs churnOf all the shares traded in a day, the share that actually changed hands and went into someone's demat account, rather than being bought and sold the same day.
100%Near average
today 100%20d avg 86.9%

The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.

vs 50 DMAHow far today's close is above or below the average closing price of the last 50 trading days. It shows the medium-term trend.▼ 1.6%vs 200 DMAHow far today's close is above or below the average closing price of the last 200 trading days, about ten months. It is the most watched line for the long-term trend.▼ 21.5%1 monthHow much the share price has changed over the period.▼ 8.0%3 monthsHow much the share price has changed over the period.▼ 18.7%1 yearHow much the share price has changed over the period.▼ 44.4%Vol 30dHow much the share has actually been moving day to day, stated as a yearly percentage. 30% means it swung roughly 30% a year at that pace.80.7%

Returns and valuationWhat the market pays for this company and how well the business uses its money.

Books to 30 Sept 2026
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.₹162 Cr19 NovP/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.41.3xlast 4 quarters, to Sept 2026Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.2.30xbooks of Sept 2026Return on capitalHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.16.9%full year FY26Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.0.00%last 12 monthsDebt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.18xbooks of Sept 2026FCF marginOf every ₹100 of sales, how much cash was left after running the business and paying for new assets.-2.3%year to Mar 2026

Against its sectorWhere this company ranks among similar companies on each measure.

Medical Equipment & Supplies · 16 peers · medians
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.41.31vs 28.23 median
Cheapest: GKB 6.05Priciest: TARSONS 215.39
Net marginOf every ₹100 of sales, how much is left as profit after all costs, interest and tax.3.4%vs 7.06% median
Lowest: MHHL -4.14%Highest: AVIENCE 17.16%
Revenue growthHow much sales grew in the latest quarter against the same quarter a year earlier.17.5%vs 20.84% median
Lowest: FABTECH -24.2%Highest: NURECA 55.08%

Dividend historyCash the company has paid per share, year by year.

₹162 in 2023
Paid 2 of 2 yrs
what 2023's payouts come to on ₹1 lakh at today's price · nothing declared in the last twelve months
What each year paid, on ₹1 lakh
162
162
22
23

2023 paid ₹0.25 per share, about ₹162 on ₹1 lakh at today's price. Dividends are at the company's discretion and can be cut or skipped.

What it has returnedThe yearly growth rate in the share price over each period, as if it had grown smoothly.

Price only, before dividends
-16.6%a year, over 3 years
1 yr
-44.2%
3 yr
-16.6%

Held for 3 years this compounded at -16.6% a year. The last twelve months were down -44.2%. Price only, before dividends.

Shareholding patternThe share of the company held by its promoters, by foreign and domestic institutions, and by the public, quarter by quarter.

Who owns it
66.34%promoter holding, as of 2026-09-30+0.0 pts since 2022
Promoter share since listing
2022-0266.34% now, drawn to its own range2026-09

The promoter/promoter-group stake as a percentage of total shares, each quarter since listing. A rising line means promoters are adding to their stake; a falling one often means dilution, pledge-driven sales, or stake sales to new investors.

Recent announcementsThe company's own filings to the exchange in the last six months: results, board meetings, investor calls and more, each with its source document.

Last 6 months
Outcome of Board Meeting18-Nov-2026

Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

Outcome of Board Meeting05-Nov-2026

Vaidya Sane Ayurved Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

General Updates15-Oct-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about General Updates

Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter13-Oct-2026

Vaidya Sane Ayurved Laboratories Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__

Certificate under SEBI (Depositories and Participants) Regulations, 201813-Oct-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

Shareholders meeting01-Oct-2026

Vaidya Sane Ayurved Laboratories Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.

Shareholders meeting30-Sep-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026

Trading Window24-Sep-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Structural Digital Database22-Sep-2026

Reply to Query - Submission of PCS Certificate pursuant to NSE mail on SDD Non-Compliance

General Updates09-Sep-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about General Updates

Shareholders meeting05-Sep-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026

Outcome of Board Meeting04-Sep-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on September 04, 2026.

Statement of deviation(s) or variation(s) under Reg. 3218-Aug-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32

Resignation of Director/KMP/SMP24-Jul-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMP

Outcome of Board Meeting24-Jul-2026

Vaidya Sane Ayurved Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026.

Backtest idea · MADHAVBAUGMACD momentum

Momentum turning up, only while the long trend is up.

BuyMACD crosses above signal, price above 200-day SMA
SellMACD crosses back below
Real prices · every charge countedRun on MADHAVBAUG
Backtest idea · MADHAVBAUGLower band bounce

Buys a stretch below the usual range, sells on the way back.

BuyCloses below the lower Bollinger band
SellBack at the middle band, or 15 days
Real prices · every charge countedRun on MADHAVBAUG
Backtest idea · MADHAVBAUGSupertrend rider

Stays in while the trend line says up, out when it flips.

BuySupertrend turns up
SellSupertrend turns down
Real prices · every charge countedRun on MADHAVBAUG
Your own ideaWrite a rule for MADHAVBAUG in plain English“Buy MADHAVBAUG when …”
Start writing
Buy the dip on MADHAVBAUGBuy when RSI(14) drops below 30
52-week high breakout on MADHAVBAUGBuy when closes at a 52-week high
Golden cross on MADHAVBAUGBuy when 50-day EMA crosses above 200-day
Stochastic oversold on MADHAVBAUGBuy when stochastic %K drops below 20
Pullback in an uptrend on MADHAVBAUGBuy when RSI(14) below 40, price above 200-day EMA

Key ratios at a glanceThe eight figures most people check first, each placed against companies in the same industry.

Against its sector
Market capWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.
₹162 cr
Larger than 25% of 16 peers
sector middle ₹560 cr
P/EHow many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.
41.3x
Higher than 58% of 12 peers
sector middle 28.2x
Price to bookThe share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.
2.3x
Around the middle of 14 peers
sector middle 2.4x
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.
16.9%
Higher than 75% of 12 peers
sector middle 11.4%
FY25 15.6%FY26 16.9%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.
0.18
Around the middle of 14 peers
sector middle 0.17
FY25 0.02FY26 0.04
Dividend yieldThe cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
0.0%
Lower than 38% of 16 peers
sector middle 0.0%
Sales growthHow much sales grew in the latest quarter against the same quarter a year earlier.
+17.5%
Lower than 56% of 9 peers
sector middle +20.8%

Peers are the listed companies in the exchange's own industry group: Medical Equipment & Supplies. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.

Cash flowProfit is an accounting figure. Cash flow shows the money that really moved: in from the business, out on investments, and to or from lenders and shareholders.

Where the cash went

In FY26 cash fell by ₹2 Cr, after ₹8 Cr spent on plant and equipment.

FY26Cash in or out
Running the business+₹5 Cr
Investing-₹24 Cr
Lenders and shareholders+₹17 Cr
Net change in cash-₹2 Cr

Health check, year by yearMargins, returns and debt for each financial year, so you can see the direction.

MeasureFY25FY26
ROCEHow much operating profit the company made on all the money in the business, whether it came from owners or lenders.15.6%16.9%
Debt to equityBorrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.0.02x0.04x

Each row against this company's own usual level: green better, red worse, grey close to it.

Backtest idea · MADHAVBAUGStochastic oversold

Buys when the close sits near the bottom of its recent range.

BuyStochastic %K drops below 20
Sell8% profit, or after 15 days
Real prices · every charge countedRun on MADHAVBAUG
Backtest idea · MADHAVBAUGPullback in an uptrend

Buys a pause inside a rising trend.

BuyRSI(14) below 40, price above 200-day EMA
Sell8% profit, or after 30 days
Real prices · every charge countedRun on MADHAVBAUG
Backtest idea · MADHAVBAUGBuy the dip

Buys after a sharp fall, betting on a bounce.

BuyRSI(14) drops below 30
Sell10% profit, or after 20 days
Real prices · every charge countedRun on MADHAVBAUG
Backtest idea · MADHAVBAUG52-week high breakout

Buys strength, when the price makes a new one-year high.

BuyCloses at a 52-week high
Sell8% stop loss
Real prices · every charge countedRun on MADHAVBAUG
Backtest idea · MADHAVBAUGGolden cross

Follows the long trend: in when the fast average crosses above the slow one.

Buy50-day EMA crosses above 200-day
SellWhen it crosses back below
Real prices · every charge countedRun on MADHAVBAUG
MACD momentum on MADHAVBAUGBuy when MACD crosses above signal, price above 200-day SMA
Lower band bounce on MADHAVBAUGBuy when closes below the lower Bollinger band
Supertrend rider on MADHAVBAUGBuy when supertrend turns up
Buy the dip on MADHAVBAUGBuy when RSI(14) drops below 30
52-week high breakout on MADHAVBAUGBuy when closes at a 52-week high

Peers side by sideCompanies in the same exchange-defined industry group, largest first. Tap a heading to sort.

Medical Equipment & Supplies
CompanyWhat the whole company is worth on the stock market: share price times the number of shares. It measures size, not quality.How many rupees investors pay today for one rupee of the company's yearly profit. A P/E of 20 means paying ₹20 for ₹1 of annual profit.The share price against the shareholders' money per share on the balance sheet. It asks what you pay for each rupee the owners have in the business.How much profit the company made on the shareholders' money in the business. 15% means ₹15 of profit a year on every ₹100 of owners' money.How much operating profit the company made on all the money in the business, whether it came from owners or lenders.Borrowings compared with the shareholders' money. 1 means the company owes as much as its owners have put in; 0 means no borrowings.Of every ₹100 of sales, how much is left as profit after all costs, interest and tax.How much sales grew in the latest quarter against the same quarter a year earlier.The cash paid out in a year as a percentage of today's share price. A 2% yield means ₹2 a year on a ₹100 share.
MOLBIO
Molbio Diagnostics Limited
17,590 cr-12.2x--0.22--0.00%
POLYMED
Poly Medicure Limited
16,933 cr53.2x5.2x10.8%13.7%0.1214.8%+30.8%0.21%
TARSONS
Tarsons Products Limited
1,616 cr215.4x2.5x2.3%4.5%0.611.6%+20.8%0.00%
FISCHER
Fischer Medical Ventures Limited
1,496 cr87.9x3.2x8.1%11.5%0.114.3%+24.5%0.22%
LAXMIDENTL
Laxmi Dental Limited
1,060 cr32.7x4.0x12.8%13.1%0.0011.0%+10.0%0.00%
QLINE
Q-Line Biotech Limited
952 cr12.8x2.0x-19.5%0.2715.4%-0.00%
DENTALKART
Vasa Denticity Limited
840 cr69.7x4.4x-9.1%0.003.8%-0.00%
FABTECH
Fabtech Technologies Limited
593 cr15.7x1.4x9.1%11.3%0.079.2%-24.2%0.45%
OSELDEVICE
Osel Devices Limited
527 cr23.8x2.3x-23.9%0.649.5%-0.34%
QMSMEDI
QMS Medical Allied Services Limited
331 cr-3.6x--0.86--0.29%
NURECA
Nureca Limited
285 cr60.7x1.5x1.1%3.3%0.012.7%+55.1%0.00%
APRAMEYA
Aprameya Engineering Limited
238 cr-------0.00%
MADHAVBAUG
Vaidya Sane Ayurved Laboratories Limited
162 cr41.3x2.3x-16.9%0.183.4%+17.5%0.00%
AVIENCE
Avience Biomedicals Limited
138 cr12.2x2.2x-23.2%0.4417.2%-0.00%
MHHL
Mohini Health & Hygiene Limited
49 cr-0.5x--9.9%1.62-4.1%+50.2%0.00%
GKB
GKB Ophthalmics Limited
30 cr6.0x----3.2%+8.5%0.00%
GML
Galaxy Medicare Limited
26 cr8.7x0.6x-11.2%0.107.1%+7.8%4.15%

Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.

Monthly price changeThe share's price change in every calendar month, one row per year, so you can check for yourself whether a month has a pattern.

Month by month
YearJanFebMarAprMayJunJulAugSepOctNovDecYear
2026
-20.4
-4.5
-22.9
+47.7
-25.7
-1.1
+7.1
-12.7
+2.1
-21.2
+13.6
·
-45.7%
11m
2025
-10.1
-22.0
-3.5
+33.4
+20.6
+5.4
+46.7
+21.3
+2.5
-6.7
+1.0
+4.2
+105.4%
2024
+2.5
-1.5
-18.5
+13.7
-19.6
+5.7
-18.1
+9.1
-4.9
-4.7
+7.4
-5.1
-34.5%
2023
+15.6
-2.4
+15.7
-2.9
+10.4
-2.1
+27.7
+10.2
-10.7
-5.2
-22.0
-7.7
+17.6%
2022
·
·
+63.1
-2.6
-5.2
-14.0
-7.4
-2.4
-1.4
-4.1
+4.9
+29.7
+50.6%
10m
Monthly movebelow -10%-10 to -5-5 to -2-2 to 00 to +2+2 to +5+5 to +10above +10%month in progress

Month-on-month change in closing price, adjusted for splits and bonuses but not for dividends, so a large dividend shows up here as a fall. Starts from 1995, when the exchange began trading equities, or from the stock's listing if later. This is a record of what happened, not a forecast.

Deals and filingsLarge trades reported to the exchange, plus the company's documents sorted by type.

DatePartySideQuantityPriceValue
2022-02-24DHYANAM CAPITAL · bulkBUY1,52,000₹101.90₹1.55 Cr
2022-02-23DHYANAM CAPITAL · bulkBUY2,64,000₹101.77₹2.69 Cr
2022-02-23SHARAD HARLALKA · bulkBUY64,000₹106.94₹0.68 Cr

Read enough? Test MADHAVBAUG. “Buy MADHAVBAUG when RSI(14) drops below 30, sell at 10% profit or after 20 days.” Real prices, every charge counted.

Run it free